Prevention of Noise-induced Damage by Use of Antioxidants

Status Recruiting

Clinical Trial Summary

The current study is a dubble-blinde placebo-controlled cross-over study verifying the preventive effect of antioxidants on noise-induced hearing loss (NIHL) and noise-induced tinnitus (NIT). The antioxidants comprise of a mixture of magnesium and n-acetylcystein which should be taken 1h before leisure noise above 100dB for at least 30 minutes.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01727492
Study type	Interventional
Source	University Hospital, Antwerp
Contact	Annick Gilles, Master
Phone	32 3 821 52 80
Email	annick.gilles@uza.be
Status	Recruiting
Phase	N/A
Start date	November 2012

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02903355` - Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)	Phase 3
Terminated	`NCT01345474` - Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)	Phase 3
Withdrawn	`NCT02049073` - Prevention of Noise-induced Hearing Loss	Phase 1/Phase 2
Completed	`NCT02257983` - Protective Effects of EPI-743 on Noise-Induced Hearing Loss	Phase 2
Completed	`NCT02259595` - Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC	Phase 1
Completed	`NCT00808470` - Micronutrients to Prevent Noise-induced Hearing Loss	Phase 2
Completed	`NCT01454895` - Test of a Web-based Intervention to Promote Hearing Protector Use	N/A
Completed	`NCT02472821` - Test of Hearing Health Education Programs for Farm and Rural Youth	N/A